Effects of platelet activating factor on the tubotympanic mucosa and inner ear in the guinea pig

Annals of Otology, Rhinology and Laryngology

Volumn 107, Issue 10 II, 1998, Pages 876-884

  Ohno, Yoshiharu ^a   Ohashi, Yoshihiro ^a   Sugiura, Yoshikazu ^a   Okamoto, Hideki ^a   Nakai, Yoshiaki ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Inner ear; Middle ear; Mucociliary function; Platelet activating factor

Indexed keywords

THROMBOCYTE ACTIVATING FACTOR;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CILIARY MOTILITY; CONTROLLED STUDY; EARDRUM; FEMALE; GUINEA PIG; MACROPHAGE; MIDDLE EAR MUCOSA; NONHUMAN; OTITIS MEDIA; PERCEPTION DEAFNESS; PRIORITY JOURNAL;

ANIMALS; CULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; EAR, INNER; EAR, MIDDLE; FEMALE; GUINEA PIGS; INJECTIONS; MICROSCOPY, ELECTRON; MUCOCILIARY CLEARANCE; MUCOUS MEMBRANE; PLATELET ACTIVATING FACTOR;

EID: 0031667897     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348949810701012     Document Type: Article

References (29)

1. Benveniste J, Henson PM, Cochrane CG. Leukocyte-dependent histamine release from rabbit platelets. J Exp Med 1972;136:1356-77.
2. Lee TC, Lenihan DJ, Malone B, Roddy LL, Wasserman SI. Increased biosynthesis of platelet activating factor in activated human eosinophils. J Biol Chem 1984;259:5526-30.
3. McIntyre TM, Zimmerman GA, Prescott SM. Leukotrienes C4 and D4 stimulate human endothelial cells to synthesize platelet-activating factor and bind neutrophils. Proc Natl Acad Sci USA 1986;83:2204-8.
4. Prescott SM, Zimmerman GA, McIntyre TM. Platelet-activating factor. J Biol Chem 1990;265:17381-4.
5. Archer CB, MacDonald DM, Morley J, Page CP, Paul W, Sanjar S. Effects of serum albumin, indomethacin and histamine H1-antagonists on Paf-acether induced inflammatory responses in the skin of experimental animals and man. Br J Pharmacol 1985;85:109-13.
6. Shaw JO, Pinckard RN, Fervigni KS, McManus LM, Hanahan DJ. Activation of human neutrophils with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine (platelet-activating factor). J Immunol 1981;127:1250-5.
7. Rubin A-HE, Smith LJ, Patterson R. The bronchoconstrictor properties of platelet-activating factor in humans. Am Rev Respir Dis 1987;136:1145-51.
8. Ohashi Y, Nakai Y. Current concepts of mucociliary dysfunction in otitis media with effusion. Acta Otolaryngol Suppl (Stockh) 1991(suppl 486):149-61.
9. Thierry A, Doly M, Braquet P, Cluzel J, Meyniel G. Presence of specific platelet-activating factor binding sites in the rat retina. Eur J Pharmacol 1989;163:97-101.
10. Bussolino F, Pescarmona G, Camussi G, Gremo F. Acetylcholine and dopamine promote the production of platelet activating factor in immature cells of chick embryonic retina. J Neurochem 1988;51:1755-9.
11. Ohashi Y, Nakai Y, Kihara S, Ikeoka H. Effects of Staphylococcus aureus on the ciliary activity of the middle ear lining. Ann Otol Rhinol Laryngol 1987;96:225-8.
12. Ohashi Y, Nakai Y, Koshimo H, Esaki Y. Ciliary activity in the in vitro tubotympanum. Arch Otorhinolaryngol 1986;243:317-9.
13. Ohashi Y, Nakai Y, Zushi K, et al. Functional and morphological studies on chronic sinusitis mucous membrane. Acta Otolaryngol [Suppl] (Stockh) 1983(suppl 397).
14. Ohashi Y, Nakai Y, Esaki Y, Ohno Y, Sugiura Y, Okamoto H. Influenza A virus-induced otitis media and mucociliary dysfunction in the guinea pig. Acta Otolaryngol Suppl (Stockh) 1991(suppl 486):135-48.
15. Van Cauwenberge PB, Bernstein LM. Inflammatory mediators in middle ear disease. In: Bernstein JM, Ogra PL, eds. Immunology of the ear. New York, NY: Raven Press, 1987:331-43.
16. Furukawa M, Kubo N, Yamashita T. Biochemical evidence of platelet-activating factor (PAF) in human middle ear effusions. Laryngoscope 1995;105:188-91.
17. Rhee C-K, Jung TTK, Miller S, Weeks D. Experimental otitis media with effusion induced by platelet activating factor. Ann Otol Rhinol Laryngol 1993;102:600-5.
18. Ganbo T, Hisamatsu K. Mucosal dysfunction and damage induced by platelet activating factor (PAF). Acta Otolaryngol (Stockh) 1990;110:427-36.
19. Blank ML, Lee T, Fitzgerald V, Snyder F. A specific acetylhydrolase for 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a hypotensive and platelet-activating lipid). J Biol Chem 1981;256:175-8.
20. Rouis M, Nigon F, Chapman J. Platelet activating factor is a potent stimulant of the production of active oxygen species by human monocyte-derived macrophages. Biochem Biophys Res Commun 1988;156:1293-301.
21. Ohashi Y, Nakai Y, Ohno Y, et al. Morphology, physiology and pathology of eustachian tube. Pathophysiology of the mucociliary system in the eustachian tube. Otol Jpn 1995;5:179-88.
22. Ohashi Y, Nakai Y, Okamoto H, et al. Platelet-activating factor-induced mucosal injury in the trachea of the guinea pig. J Jpn Bronchoesophagol Soc 1991;42:438-45.
23. Ohashi Y, Ohno Y, Sugiura Y, et al. Presence of bronchoalveolar lavage fluid necessary for platelet activating factor-induced ciliary depression. Int Arch Allergy Immunol 1994;104:302-6.
24. Paparella MM, Goycoolea MV, Meyerhoff WL. Inner ear pathology and otitis media. A review. Ann Otol Rhinol Laryngol [Suppl] 1980;89(suppl 68):249-53.
25. Tos M. Sensorineural hearing loss in acute and chronic middle ear diseases. Acta Otolaryngol [Suppl] (Stockh) 1988 (suppl 457):87-93.
26. Morizono T, Hamaguchi Y, Juhn SK. Sensorineural hearing loss in antigen-induced otitis media. Acta Otolaryngol [Suppl] (Stockh) 1988(suppl 457):67-72.
27. Blank ML, Snyder F, Byers LW, Brooks B, Muirhead EE. Antihypertensive activity of alkyl ether analog of phosphorylcholine. Biochem Biophys Res Commun 1979;90:1194-200.
28. Ohashi Y, Nakai Y, Kato M. Electron microscopic study of the inner ear following anaphylaxis, Ann Otol Rhinol Laryngol 1987;96:340-2.
29. Spoendlin H. Das ischmisch Syndrom des Innenohres. Pract Otorhinolaryngol 1969;31:259-68.